In last trading session, Adicet Bio Inc. (NASDAQ:ACET) saw 0.72 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $13.90 trading at $0.24 or 1.76% at ring of the bell on the day assigns it a market valuation of $644.26M. That closing price of ACET’s stock is … Adicet Bio Inc. (NASDAQ:ACET) Currently -52.3% Below Its 52-Week High, But There May Be A Surprise Downside Read More »
During the last session, Adicet Bio Inc. (NASDAQ:ACET)’s traded shares were 0.79 million, with the beta value of the company hitting 2.42. At the end of the trading day, the stock’s price was $13.63, reflecting an intraday gain of 13.39% or $1.61. The 52-week high for the ACET share is $21.17, that puts it down … Following Its 52-Week Low, Adicet Bio Inc. (NASDAQ: ACET)’S Share Price Rose 54.15% And Its YTD Numbers Fell -22.07% Read More »
In last trading session, Adicet Bio Inc. (NASDAQ:ACET) saw 1.12 million shares changing hands with its beta currently measuring 2.61. Company’s recent per share price level of $12.80 trading at -$0.41 or -3.10% at ring of the bell on the day assigns it a market valuation of $511.62M. That closing price of ACET’s stock is … Adicet Bio Inc. (NASDAQ:ACET) Stock Ripped -26.82% Year-To-Date, What Will Happen Next? Read More »
During the last session, Adicet Bio Inc. (NASDAQ:ACET)’s traded shares were 0.57 million, with the beta value of the company hitting 2.65. At the end of the trading day, the stock’s price was $11.50, reflecting an intraday gain of 0.09% or $0.01. The 52-week high for the ACET share is $21.17, that puts it down … Will Adicet Bio Inc. (NASDAQ: ACET) Stock Boom Or Bust From Here? Read More »
In the last trading session, 1.1 million shares of the Adicet Bio Inc. (NASDAQ:ACET) were traded, and its beta was 2.65. Most recently the company’s share price was $11.82, and it changed around $0.07 or 0.60% from the last close, which brings the market valuation of the company to $412.87M. ACET currently trades at a … Future Outlook And Stock Price Performance For Adicet Bio Inc. (NASDAQ: ACET) Read More »
The report presents an in-depth assessment of the Pharmaceutical Intermediates Market including enabling technologies, key trends, market drivers, challenges, regulatory landscape, deployment models, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Pharmaceutical
Following a joint investigation by the OSC and Royal Canadian Mounted Police (RCMP), Integrated Market Enforcement Team (IMET), three former directors and officers at CannTrust Holdings Inc. (CannTrust) have been charged with offences under the Securities Act (Ontario). Charges include: Mark Litwin from Toronto, Ontario: Fraud Insider trading Making a false prospectus and false preliminary prospectus Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence Eric Paul from Toronto, Ontario: Fraud Insider trading Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence. Peter Aceto from Toronto, Ontario: Fraud Making false or misleading statements to the OSC and to the market Making a false prospectus and false preliminary prospectus Authorizing, permitting or acquiescing in the commission of an offence These allegations relate to efforts to conceal the illegal growing of cannabis at CannTrust over a 10-month period in 2018 and 2019.
Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients, regulatory starting materials and advanced intermediates.
DSK Legal advised Finar Limited and its promoters Girish Maheshwari, Amit Maheshwari and other selling shareholders. Aceto executed the acquisition of a majority stake in Indian []
Global Pharmaceutical Intermediates Market size, share and CAGR Analysis 2021-2027 Pharmaceutical Intermediates Market report performs comprehensive Analysis about Global Market and tells about the market status in the forecast period. The report recognizes and analyses the growing trends along with major drivers, restraints, challenges and opportunities in the Pharmaceutical Intermediates industry. The market research report []
Aceto , a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today the acquisition of a majority stake in Finar Limited. Finar is a leading manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food grade additives.
The Global Benzocaine Market report provides a holistic evaluation of the market for the forecast period (2018–2026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the
Earlier today, at the federal courthouse in Central Islip, Douglas Roth, the former Chief Financial Officer (CFO) of Aceto Corporation (Aceto), a pharmaceutical company based in Port Washington, New York, pleaded guilty to securities fraud for insider trading.
The U.S. Securities and Exchange Commission sued the former chief financial officer of Aceto Corp in Brooklyn federal court on Thursday alleging he learned inside information about the now-defunct generic drug company's precarious financial condition before his 2018 retirement…